Technology News and Research

RSS

Using wastewater-based epidemiology to monitor monkeypox

Monkeypox, a virus that causes painful rashes and flu-like symptoms, is spreading rapidly throughout many parts of the world, including the U.S. To get a fast understanding of how the virus is moving through communities, researchers reporting in ACS' Environmental Science & Technology Letters suggest turning to wastewater epidemiology.

8 Sep 2022

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

The National Institutes of Health has issued two new funding opportunities for diagnostic test manufacturers to develop the next generation of COVID-19 tests, with a major focus on accessibility.

8 Sep 2022

Researchers harness stem cells to study how Ebola virus infects and damages the liver

The Ebola virus was first identified in 1976 near the Ebola River in the Democratic Republic of the Congo. Since then, there have been periodic outbreaks of Ebola Virus Disease (EVD), mostly in Africa, resulting in 13,700 deaths worldwide.

8 Sep 2022

How does a walk in nature impact the brain?

A new study shows how exposure to nature through a one-hour walk in a natural setting can prevent mental strain and possibly reduce the incidence of mental ill-health.

8 Sep 2022

Cancer risk higher among children born after frozen-thawed embryo transfer

In a recent PLOS Medicine journal study, scientists have documented that children born after ART, particularly FET, are at an increased risk of developing childhood cancer than those born after spontaneous conception and fresh embryo transfer.

8 Sep 2022

Wearable assistive robot can detect and prevent a fall before it happens

Researchers at Nanyang Technological University, Singapore (NTU Singapore) and Tan Tock Seng Hospital (TTSH) have developed a wearable assistive robot that can detect and prevent a fall before it happens, reducing the user's risk of sustaining injuries.

7 Sep 2022

First nasal vaccine for COVID-19 approved in India for emergency use

The world's first nasal vaccine for COVID-19 was approved Tuesday, Sept. 6, in India for emergency use. The vaccine, called iNCOVACC, is based on technology licensed from Washington University in St. Louis and developed in collaboration with Bharat Biotech International Limited in India.

7 Sep 2022

Novel skin imaging technology improves the accuracy of basal cell carcinoma diagnosis

A novel imaging technique significantly improves the accuracy of the diagnosis of basal cell carcinoma (BCC) – the most frequent skin cancer – compared to clinical and dermoscopic examinations alone, according to new research being presented at the 31st European Academy of Dermatology and Venereology Congress.

7 Sep 2022

New tool uses artificial intelligence to calculate harmful effects of medicines

Research led by the University of Exeter and Kent and Medway NHS and Social Care Partnership Trust, published in Age and Ageing, assessed a new tool designed to calculate which medicines are more likely to experience adverse anticholinergic effects on the body and brain.

7 Sep 2022

Photocatalyst-based ViraMap platform maps SARS-CoV-2 spike protein interactions on the cell surface

Researchers performed the photocatalytic mapping of the SARS-CoV-2 spike protein-host cell membrane interactions.

7 Sep 2022

New US Subsidiary for BioEcho Life Sciences

BioEcho Life Sciences, a Germany-based biotechnology company supplying the fastest and most sustainable nucleic acid extraction technology, announces the opening of its US subsidiary in Boston, MA.

From BioEcho Life Sciences GmbH 7 Sep 2022

New OCTARAY™ Mapping Catheter with TRUEref™ Technology from Biosense Webster

The OCTARAY™ Mapping Catheter with TRUEref™ Technology provides physicians with the precise information needed for catheter ablation procedures that treat cardiac arrhythmias.

From Johnson & Johnson 7 Sep 2022

Organ transplants are up, but the agency in charge is under fire

For the past decade, Precious McCowan's life has revolved around organ transplants. She's a doctoral candidate studying human behavior in Dallas who has survived two kidney transplants. And in the midst of her end-stage renal disease, her 2-year-old son died. She chose to donate his organs in hopes they would save a life.

7 Sep 2022

Creoptix launches new WAVEcontrol software to deliver automated, flexible and intuitive label-free interaction analysis for biologics drug-discovery

Creoptix® (a Malvern Panalytical brand) is announcing the addition of two new wizards to their WAVEcontrol software to simplify and streamline workflows. By combining the high sensitivity, throughput, and no-clog microfluidics of the WAVEsystem, with a faster, more flexible, automated approach to screening and characterization, Creoptix is accelerating biologics drug discovery and diagnostics development.

From Malvern Panalytical 7 Sep 2022

Researchers develop universally accessible application that can simulate complex molecular interactions

A team led by University of Minnesota Twin Cities biomedical engineers has developed a universally accessible application that can simulate complex molecular interactions, which will allow researchers to design better treatments for diseases like cancer and COVID-19.

6 Sep 2022

Single-cell Stereo-seq reveals new insights into axolotl brain regeneration

The axolotl Ambystoma mexicanum is a popular pet due to its unique and cute appearance. Unlike other salamanders undergoing metamorphosis, axolotls (pronounced ACK-suh-LAH-tuhl) never outgrow their larval, juvenile stage, a phenomenon called neoteny.

6 Sep 2022

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

Over the past few decades, very few new antibiotics have been developed, largely because current methods for screening potential drugs are prohibitively expensive and time-consuming.

6 Sep 2022

Pioneering method could contribute to global manufacturing of essential molecules

University of Queensland researchers have pioneered a new chemical process to manufacture the molecules that are the building blocks for lifesaving medicines, vaccines and energy storage materials.

6 Sep 2022

Metabolic signature could be a potential target for new breast cancer therapies

Despite advancements in cancer detection and treatment, breast cancer that comes back or spreads still presents a challenge to researchers and oncologists.

6 Sep 2022

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Magnus Medical, Inc., a medical device company and developer of brain stimulation technology for treatment of neuropsychiatric disorders, today announced it received 510(k) clearance from the U.S. Food & Drug Administration for the SAINTTM Neuromodulation System for the treatment of major depressive disorder (MDD) in adults who have failed to achieve satisfactory improvement from prior antidepressant medications in the current episode.

6 Sep 2022

Technology News and Research

Using wastewater-based epidemiology to monitor monkeypox

NIH issues funding opportunities to support the development of new COVID-19 diagnostics

Researchers harness stem cells to study how Ebola virus infects and damages the liver

How does a walk in nature impact the brain?

Cancer risk higher among children born after frozen-thawed embryo transfer

Wearable assistive robot can detect and prevent a fall before it happens

First nasal vaccine for COVID-19 approved in India for emergency use

Novel skin imaging technology improves the accuracy of basal cell carcinoma diagnosis

New tool uses artificial intelligence to calculate harmful effects of medicines

Photocatalyst-based ViraMap platform maps SARS-CoV-2 spike protein interactions on the cell surface

New US Subsidiary for BioEcho Life Sciences

New OCTARAY™ Mapping Catheter with TRUEref™ Technology from Biosense Webster

Organ transplants are up, but the agency in charge is under fire

Creoptix launches new WAVEcontrol software to deliver automated, flexible and intuitive label-free interaction analysis for biologics drug-discovery

Researchers develop universally accessible application that can simulate complex molecular interactions

Single-cell Stereo-seq reveals new insights into axolotl brain regeneration

Advances in modeling molecular interactions needed to better harness AlphaFold for drug discovery

Pioneering method could contribute to global manufacturing of essential molecules

Metabolic signature could be a potential target for new breast cancer therapies

Magnus’ SAINT Neuromodulation System receives 510(k) clearance from FDA for treatment of major depressive disorder

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News